Guanglei Chang

767 total citations
23 papers, 619 citations indexed

About

Guanglei Chang is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Guanglei Chang has authored 23 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 8 papers in Molecular Biology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Guanglei Chang's work include Cardiac Ischemia and Reperfusion (4 papers), Cardiovascular Function and Risk Factors (3 papers) and Cardiac Fibrosis and Remodeling (3 papers). Guanglei Chang is often cited by papers focused on Cardiac Ischemia and Reperfusion (4 papers), Cardiovascular Function and Risk Factors (3 papers) and Cardiac Fibrosis and Remodeling (3 papers). Guanglei Chang collaborates with scholars based in China, United States and Canada. Guanglei Chang's co-authors include Shu Qin, Ying Wang, Dongying Zhang, Peng Zhang, Kai Lü, Dongying Zhang, Lei Gao, Liyou Wang, Dan Jiang and Jian Liu and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Experimental Cell Research and Life Sciences.

In The Last Decade

Guanglei Chang

21 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guanglei Chang China 11 267 181 123 114 101 23 619
Hu Xu China 16 245 0.9× 118 0.7× 71 0.6× 71 0.6× 81 0.8× 41 687
Yitong Ma China 17 304 1.1× 140 0.8× 190 1.5× 68 0.6× 86 0.9× 67 766
Zhiming Ge China 16 317 1.2× 198 1.1× 61 0.5× 67 0.6× 212 2.1× 38 775
Loubina Fazal France 11 347 1.3× 244 1.3× 95 0.8× 46 0.4× 102 1.0× 17 650
Ruihai Zhou United States 17 337 1.3× 133 0.7× 71 0.6× 222 1.9× 172 1.7× 40 904
Chunpeng Zou China 14 310 1.2× 211 1.2× 80 0.7× 37 0.3× 92 0.9× 35 799
Jon Vincelette United States 15 205 0.8× 228 1.3× 128 1.0× 60 0.5× 123 1.2× 24 775
Kyle T. Keyes United States 7 206 0.8× 102 0.6× 109 0.9× 66 0.6× 80 0.8× 7 492
Xuwei Hou China 19 355 1.3× 183 1.0× 86 0.7× 95 0.8× 228 2.3× 38 980
Youchun Jiang United States 10 371 1.4× 328 1.8× 104 0.8× 119 1.0× 120 1.2× 10 942

Countries citing papers authored by Guanglei Chang

Since Specialization
Citations

This map shows the geographic impact of Guanglei Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guanglei Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guanglei Chang more than expected).

Fields of papers citing papers by Guanglei Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guanglei Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guanglei Chang. The network helps show where Guanglei Chang may publish in the future.

Co-authorship network of co-authors of Guanglei Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Guanglei Chang. A scholar is included among the top collaborators of Guanglei Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guanglei Chang. Guanglei Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yao, Suwei, Chen Li, Wei Yang, et al.. (2024). Geniposide alleviates post-myocardial infarction-induced pyroptosis by modulating the thioredoxin-interacting protein/NLRP3 signaling pathway. CytoJournal. 21. 80–80. 1 indexed citations
3.
4.
Chang, Guanglei, et al.. (2023). Doxorubicin inhibits cholesterol efflux through the miR-33/ABCA1 pathway. Biochemical and Biophysical Research Communications. 644. 149–154. 2 indexed citations
5.
Zhang, Hanwen, Weiwei Hu, Yu Wang, et al.. (2022). The relationship between ambulatory arterial stiffness index and left ventricular diastolic dysfunction in HFpEF: a prospective observational study. BMC Cardiovascular Disorders. 22(1). 246–246. 2 indexed citations
6.
Cheng, Xiaocheng, Liyou Wang, Xuesong Wen, et al.. (2021). TNAP is a novel regulator of cardiac fibrosis after myocardial infarction by mediating TGF-β/Smads and ERK1/2 signaling pathways. EBioMedicine. 67. 103370–103370. 33 indexed citations
7.
Wen, Xuesong, Guanglei Chang, Rui Xia, et al.. (2021). ST-segment resolution as a marker for severe myocardial fibrosis in ST-segment elevation myocardial infarction. BMC Cardiovascular Disorders. 21(1). 455–455. 3 indexed citations
8.
Gao, Lei, Liyou Wang, Zhiqiang Liu, et al.. (2020). TNAP inhibition attenuates cardiac fibrosis induced by myocardial infarction through deactivating TGF-β1/Smads and activating P53 signaling pathways. Cell Death and Disease. 11(1). 44–44. 53 indexed citations
9.
Jiang, Dan, Min Sun, Linna You, et al.. (2019). DNA methylation and hydroxymethylation are associated with the degree of coronary atherosclerosis in elderly patients with coronary heart disease. Life Sciences. 224. 241–248. 40 indexed citations
10.
Jiang, Dan, Ying Wang, Guanglei Chang, et al.. (2019). DNA hydroxymethylation combined with carotid plaques as a novel biomarker for coronary atherosclerosis. Aging. 11(10). 3170–3181. 14 indexed citations
11.
12.
Wu, Shiyong, Guanglei Chang, Lei Gao, et al.. (2018). Trimetazidine protects against myocardial ischemia/reperfusion injury by inhibiting excessive autophagy. Journal of Molecular Medicine. 96(8). 791–806. 88 indexed citations
13.
Zhang, Peng, Chunxiao Hu, Yongyong Li, et al.. (2018). Vangl2 is essential for myocardial remodeling activated by Wnt/JNK signaling. Experimental Cell Research. 365(1). 33–45. 4 indexed citations
14.
15.
Hu, Chunxiao, et al.. (2016). 15-Lipoxygenase-1 Is Involved in the Effects of Atorvastatin on Endothelial Dysfunction. Mediators of Inflammation. 2016. 1–12. 8 indexed citations
16.
Chang, Guanglei, et al.. (2016). Simvastatin ameliorates ventricular remodeling via the TGF-β1 signaling pathway in rats following myocardial infarction. Molecular Medicine Reports. 13(6). 5093–5101. 29 indexed citations
17.
18.
Lü, Kai, et al.. (2015). Protective effects of extendin-4 on hypoxia/reoxygenation-induced injury in H9c2 cells. Molecular Medicine Reports. 12(2). 3007–3016. 10 indexed citations
19.
Chang, Guanglei, Dongying Zhang, Hui Yu, et al.. (2013). Cardioprotective effects of exenatide against oxidative stress-induced injury. International Journal of Molecular Medicine. 32(5). 1011–1020. 73 indexed citations
20.
Chang, Guanglei, Peng Zhang, Lin Ye, et al.. (2013). Protective effects of sitagliptin on myocardial injury and cardiac function in an ischemia/reperfusion rat model. European Journal of Pharmacology. 718(1-3). 105–113. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hu Xu Breakdown of academic impact, for papers by Yitong Ma Breakdown of academic impact, for papers by Zhiming Ge Breakdown of academic impact, for papers by Loubina Fazal Breakdown of academic impact, for papers by Ruihai Zhou Breakdown of academic impact, for papers by Chunpeng Zou Breakdown of academic impact, for papers by Jon Vincelette Breakdown of academic impact, for papers by Kyle T. Keyes Breakdown of academic impact, for papers by Xuwei Hou Breakdown of academic impact, for papers by Youchun Jiang
Rankless by CCL
2026